Large language models, an emerging modern technology cornerstone, can learn the language of our genome. With this in mind, researchers recently sought to develop neural networks that can gain a latent understanding of the genomic code of life. Anthony Tao writes.
oncobites.blog/2026/03/11/f...
Researchers found that high blood lipid levels alone can drive breast cancer growth. This suggests that lowering high blood lipids could be an important way to treat or reduce the risk of breast cancer, especially for people with obesity. Neha Rai writes.
oncobites.blog/2026/03/04/o...
Colorectal organoids are tiny, 3D ‘mini-tumours’ grown in a lab from real patient tumour cells. They’ve recently been used as realistic, reliable models for evaluating 5 innovative colorectal cancer therapies. Xanthea Heighington writes.
oncobites.blog/2026/02/25/5...
AI will not replace oncologists. But it can help make cancer treatment decisions faster, more complete, and more consistent. Dr. Maanya Rajasree Katta writes.
oncobites.blog/2026/02/18/a...
The longest living mammals, the bowhead whales, weigh over 80,000 kilograms and have a lifespan of more than 200 years. Yet, they rarely develop cancer— a biological mystery that has puzzled scientists for decades. Until now. Sunetra Sen, Ph.D. writes.
oncobites.blog/2026/02/11/f...
Cell-penetrating peptides deliver drugs directly into cells but lack cell-type specificity. Scientists developed a new peptide-like compound that can take better advantage of the slightly acidic tumor environment to target cancer cells. Anamika Bandyopadhyay writes.
oncobites.blog/2026/02/04/t...
Why is cancer screening important, what current screening methods exist for some common cancers, and what can you do to help reduce your risk of cancer? Read this article to learn more. Dr. Preeti Roman writes.
oncobites.blog/2026/01/28/c...
Microplastics have been found in our blood, lungs, and brains, and their presence poses a serious health risk. So how do they connect to cancer development? New findings are suggesting two alarming scenarios. Victoria Gnazzo writes.
oncobites.blog/2026/01/21/p...
Recently, the FDA approved the drug dordaviprone for recurrent H3K27M-mutant diffuse midline glioma. This marks a historic turning point, as it is the first therapy for this rare and extremely aggressive brain tumor. Susy Prieto Huarcaya, PhD writes.
oncobites.blog/2026/01/14/d...
While it’s known that cancer cells can steal mitochondria from nearby cells, a new study shows that the opposite process - that cancer cells can transfer their mitochondria to healthy cells - is just as possible. Mariella Bodemeier Loayza Careaga writes.
oncobites.blog/2026/01/07/c...
Multi-cancer early detection (MCED) tests can detect various cancers at earlier stages using a single blood sample. MCED tests have the potential to revolutionize cancer screening by identifying a wider spectrum of cancers. Preeti Prangya Panda writes.
oncobites.blog/2025/12/22/m...
A past European Cancer Anaemia Survey found that 73% of patients with multiple myeloma were also diagnosed with anemia. What could the connection be between these two blood-related conditions? Libby-Ann Harpaul-Sahadeo writes.
oncobites.blog/2025/12/17/m...
How well do you know about current therapies and ongoing developments for B-cell lymphomas? This is a chance to test your knowledge and learn more directly afterwards! (special: includes a pre- and post-article quiz activity) Néstor Zumaya writes.
oncobites.blog/2025/12/10/p...
Ovarian cancer is the 8th most common malignancy among women and females worldwide. Because this cancer can provoke an immune response, future innovations in cancer treatment strategies are shifting towards emerging immunotherapies. Lubna Najm writes.
oncobites.blog/2025/12/03/i...
The best screening test for colorectal cancer is the one that actually gets done. Capsule and robotic-assisted colonoscopy are making that easier, addressing barriers that have kept many people from getting screened. Maanya Rajasree Katta writes.
oncobites.blog/2025/11/26/w...
Precision oncology is advancing faster than the healthcare infrastructure meant to deliver it. This gap is more representative of real consequences for patient survival, quality of life, and health equity. Shashank Gidipally, PharmD writes.
oncobites.blog/2025/11/19/b...
OncoBites is back for the next writing cycle! Stay tuned weekly for the latest in cancer research in bite-sized pieces like this!
Taxanes are chemotherapy drugs that work by inhibiting the function of cytoskeletal microtubules in cancer cells. But what happens if a toxic dosage is given? Libby-Ann Harpaul-Sahadeo writes.
oncobites.blog/2025/11/12/t...
In honor of #BreastCancerAwarenessMonth, here are our 5 latest articles on research related to breast cancer!
1) oncobites.blog/2025/05/28/t...
2) oncobites.blog/2023/05/03/a...
3) oncobites.blog/2022/09/21/a...
4) oncobites.blog/2022/03/23/b...
5) oncobites.blog/2022/02/02/y...
And that’s a wrap on our last cycle! OncoBites will be taking a short break from publishing to prepare for the new writing cycle. Thank you to all our contributors and readers so far, and we’ll be back with new content soon!
Preclinical oncology imaging is no longer a complementary tool, but an essential component of oncology drug development. Bethany Cooper writes.
oncobites.blog/2025/09/24/t...
Researchers at UCLA proposed an interesting approach to CAR-T cell therapy: using focused ultrasound to only activate CAR-T cells within a tumor. Restricting CAR-T cell activity would theoretically limit its off-target & toxic effects. Anthony Tao writes.
oncobites.blog/2025/09/17/u...
The dependence of cancer cells on various altered metabolic pathways can be exploited for therapeutic purposes. 1 new therapeutic approach is adipose manipulation transplantation, which can potentially suppress cancer cell proliferation. Colin Ong writes.
oncobites.blog/2025/09/10/a...
A recent publication illustrates the power of data sharing from tissue and data collected in three clinical trials. Patty Spears writes.
oncobites.blog/2025/09/03/p...
In a recent study, scientists have found a clear presence of immune cells, particularly T cells, in the cranial bones of patients with glioblastoma before surgery. Anna Salamero Boix writes.
oncobites.blog/2025/08/27/s...
Vaccines have been recognized as promising chemotherapeutic instruments. Advances in how we look for & select antigens, as well as new platforms & delivery methods, pave the way for developing more specific & potent cancer vaccine options. Mariella Careaga writes.
oncobites.blog/2025/08/20/a...
Taurine is one of the most important ingredients in energy drinks. In a novel study, researchers have found that taurine is not just an additive but rather a key player in the metabolic potential of cancer stem cells. Preeti Prangya Panda writes.
oncobites.blog/2025/08/13/d...
We are once again opening our call for authors! Interested in joining us? Please fill out this form by August 22:
docs.google.com/forms/d/e/1F...
If you are unable to write with us this cycle but still wish to be on the list for future calls, please still fill out the form. Thank you!
Liquid biopsy is a non-invasive blood-based test that may help increase accessibility to screening & improve early detection of colorectal cancer in younger adults. It may also help to improve outcomes after a cancer diagnosis. Nicole Bowens, PhD writes.
oncobites.blog/2025/08/06/c...
A recent study has found that a specific type of immune cell, Vd1-gd T cells, can help predict which patients are more likely to respond favorably to immunotherapy treatments. Joycelyn Ghansah, MA, MPH writes.
oncobites.blog/2025/07/30/a...
